180 related articles for article (PubMed ID: 15206712)
1. Role of IDO activation in anti-microbial defense in human native astrocytes.
Oberdörfer C; Adams O; MacKenzie CR; De Groot CJ; Däubener W
Adv Exp Med Biol; 2003; 527():15-26. PubMed ID: 15206712
[TBL] [Abstract][Full Text] [Related]
2. The mechanism of interferon-gamma induced anti Toxoplasma gondii by indoleamine 2,3-dioxygenase and/or inducible nitric oxide synthase vary among tissues.
Fujigaki S; Takemura M; Hamakawa H; Seishima M; Saito K
Adv Exp Med Biol; 2003; 527():97-103. PubMed ID: 15206721
[TBL] [Abstract][Full Text] [Related]
3. L-tryptophan-L-kynurenine pathway metabolism accelerated by Toxoplasma gondii infection is abolished in gamma interferon-gene-deficient mice: cross-regulation between inducible nitric oxide synthase and indoleamine-2,3-dioxygenase.
Fujigaki S; Saito K; Takemura M; Maekawa N; Yamada Y; Wada H; Seishima M
Infect Immun; 2002 Feb; 70(2):779-86. PubMed ID: 11796611
[TBL] [Abstract][Full Text] [Related]
4. Anti-parasitic effector mechanisms in human brain tumor cells: role of interferon-gamma and tumor necrosis factor-alpha.
Däubener W; Remscheid C; Nockemann S; Pilz K; Seghrouchni S; Mackenzie C; Hadding U
Eur J Immunol; 1996 Feb; 26(2):487-92. PubMed ID: 8617321
[TBL] [Abstract][Full Text] [Related]
5. Effect of cytokines on growth of Toxoplasma gondii in murine astrocytes.
Halonen SK; Chiu F; Weiss LM
Infect Immun; 1998 Oct; 66(10):4989-93. PubMed ID: 9746608
[TBL] [Abstract][Full Text] [Related]
6. Restriction of Toxoplasma gondii growth in human brain microvascular endothelial cells by activation of indoleamine 2,3-dioxygenase.
Däubener W; Spors B; Hucke C; Adam R; Stins M; Kim KS; Schroten H
Infect Immun; 2001 Oct; 69(10):6527-31. PubMed ID: 11553600
[TBL] [Abstract][Full Text] [Related]
7. IFN-gamma activated indoleamine 2,3-dioxygenase activity in human cells is an antiparasitic and an antibacterial effector mechanism.
Däubener W; MacKenzie CR
Adv Exp Med Biol; 1999; 467():517-24. PubMed ID: 10721095
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of indoleamine 2,3-dioxygenase in human macrophages inhibits interferon-gamma-induced bacteriostasis but does not abrogate toxoplasmastasis.
MacKenzie CR; Langen R; Takikawa O; Däubener W
Eur J Immunol; 1999 Oct; 29(10):3254-61. PubMed ID: 10540337
[TBL] [Abstract][Full Text] [Related]
9. Human indoleamine 2,3-dioxygenase inhibits Toxoplasma gondii growth in fibroblast cells.
Dai W; Pan H; Kwok O; Dubey JP
J Interferon Res; 1994 Dec; 14(6):313-7. PubMed ID: 7897249
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of antimicrobial effects by glucocorticoids.
Türck J; Oberdörfer C; Vogel T; Mackenzie CR; Däubener W
Med Microbiol Immunol; 2005 Jan; 194(1-2):47-53. PubMed ID: 14624357
[TBL] [Abstract][Full Text] [Related]
11. Potential role of human brain microvascular endothelial cells in the pathogenesis of brain abscess: inhibition of Staphylococcus aureus by activation of indoleamine 2,3-dioxygenase.
Schroten H; Spors B; Hucke C; Stins M; Kim KS; Adam R; Däubener W
Neuropediatrics; 2001 Aug; 32(4):206-10. PubMed ID: 11571701
[TBL] [Abstract][Full Text] [Related]
12. 3-Hydroxyanthranilic acid, one of metabolites of tryptophan via indoleamine 2,3-dioxygenase pathway, suppresses inducible nitric oxide synthase expression by enhancing heme oxygenase-1 expression.
Oh GS; Pae HO; Choi BM; Chae SC; Lee HS; Ryu DG; Chung HT
Biochem Biophys Res Commun; 2004 Aug; 320(4):1156-62. PubMed ID: 15249210
[TBL] [Abstract][Full Text] [Related]
13. Impact of foetus and mother on IFN-gamma-induced indoleamine 2,3-dioxygenase and inducible nitric oxide synthase expression in murine placenta following Toxoplasma gondii infection.
Pfaff AW; Mousli M; Sénégas A; Marcellin L; Takikawa O; Klein JP; Candolfi E
Int J Parasitol; 2008 Feb; 38(2):249-58. PubMed ID: 17822706
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide-mediated regulation of gamma interferon-induced bacteriostasis: inhibition and degradation of human indoleamine 2,3-dioxygenase.
Hucke C; MacKenzie CR; Adjogble KD; Takikawa O; Däubener W
Infect Immun; 2004 May; 72(5):2723-30. PubMed ID: 15102781
[TBL] [Abstract][Full Text] [Related]
15. Indoleamine 2,3-Dioxygenase Activity During Acute Toxoplasmosis and the Suppressed T Cell Proliferation in Mice.
Ufermann CM; Domröse A; Babel T; Tersteegen A; Cengiz SC; Eller SK; Spekker-Bosker K; Sorg UR; Förster I; Däubener W
Front Cell Infect Microbiol; 2019; 9():184. PubMed ID: 31231617
[No Abstract] [Full Text] [Related]
16. Expression of the kynurenine enzymes in macrophages and microglial cells: regulation by immune modulators.
Alberati-Giani D; Cesura AM
Amino Acids; 1998; 14(1-3):251-5. PubMed ID: 9871470
[TBL] [Abstract][Full Text] [Related]
17. Human primary CD4 + T cells activated in the presence of IFN-alpha 2b express functional indoleamine 2,3-dioxygenase.
Curreli S; Romerio F; Mirandola P; Barion P; Bemis K; Zella D
J Interferon Cytokine Res; 2001 Jun; 21(6):431-7. PubMed ID: 11440641
[TBL] [Abstract][Full Text] [Related]
18. Role of indoleamine-2,3-dioxygenase in alpha/beta and gamma interferon-mediated antiviral effects against herpes simplex virus infections.
Adams O; Besken K; Oberdörfer C; MacKenzie CR; Takikawa O; Däubener W
J Virol; 2004 Mar; 78(5):2632-6. PubMed ID: 14963171
[TBL] [Abstract][Full Text] [Related]
19. Regulation of indoleamine 2,3-dioxygenase gene expression in human fibroblasts by interferon-gamma. Upstream control region discriminates between interferon-gamma and interferon-alpha.
Dai W; Gupta SL
J Biol Chem; 1990 Nov; 265(32):19871-7. PubMed ID: 2174056
[TBL] [Abstract][Full Text] [Related]
20. Differential regulation of indoleamine 2,3-dioxygenase expression by nitric oxide and inflammatory mediators in IFN-gamma-activated murine macrophages and microglial cells.
Alberati-Giani D; Malherbe P; Ricciardi-Castagnoli P; Köhler C; Denis-Donini S; Cesura AM
J Immunol; 1997 Jul; 159(1):419-26. PubMed ID: 9200481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
